Patents
| Title | Publication number | Applicant* | Status |
|---|---|---|---|
| 1,2,4-triazole derivatives as tankyrase inhibitors | WO 2019243822 | Oslo Univ Hospital, FVB, Univ Oulo | Published |
| Heterocyclic compounds as class II phosphoinositide 3-kinase inhibitors | WO 2019234237 | FVB | Published |
| Polyproline mimetics of proline-derived module-15 | WO 2019162524 | FVB, Univ zu Köln | Licensed |
| Selective inhibitors of genotoxic stress-induced IKK/NF-kB pathways | WO 2018087389 | MDC, FVB | Published |
| Chemoselective thiol-conjugation with alkene or alkyne-phosphonothiolates and -phosphonates | WO 2019170710 | FVB, LMU | Licensed |
| Chemoselective thiol-conjugation with alkene or alkyne-phosphonamidates | WO 2018041985 | FVB, LMU | Licensed |
| Unusual substrates of tubulin tyrosine ligase | WO 2017186855 | FVB, LMU | Licensed |
| Antagonists of the thyroid-stimulating hormone receptor (TSHR) | WO 2017186793 | FVB | Published |
| Means and methods for site-specific functionalization of polypeptides | WO 2016066749 | LMU, FVB | Licensed |
| Xanthine derivatives, their use as a medicament, and pharmaceutical preparations comprising the same | WO 2016135199, WO 2018019917 | FVB, MDC | Licensed |
| Inhibitors for inhibiting tumor metastasis | WO 2016092069 | FVB, Univ zu Köln | Licensed |
| LRRC8 proteins and protein complexes and methods for identification of channel modulators | US 9927423 B2 | FVB, MDC | Granted |
| Structural mimetics of proline-rich peptides and use thereof | WO 2013030111 | FVB, Univ zu Köln | Licensed |
| Induction of alpha helix conformations in proteins and peptides | WO 2011003626 | Univ zu Köln, FVB | Licensed |
| Low molecular weight thyroid stimulating hormone receptor (TSHR) agonists | WO 2010047674 | US Health, FVB | Licensed |
| Structural mimetics of proline-rich peptides and the pharmaceutical use thereof | WO 2008040332 | FVB | Licensed |
*FVB - Forschungsverbund Berlin e.V. (for its Leibniz-Forschungsinstitut für Molekulare Pharmakologie); LMU - Ludwig-Maximilians-Universität München; MDC - Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft; Oslo Univ Hospital - Oslo University Hospital HF; TUM - Technische Universität München; Univ Oulo - University of Oulo; Univ zu Köln - Universität zu Köln; US Health - The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services
